Postive cancer trial resultsPotentially increases patient poolNew standard of careShares in AstraZeneca (AZN) got a further boost today, rising 2% after posting positive late-stage trial results for breast cancer treatment Enhertu which demonstrated clinically-meaningful progression-free survival improvements.This follows strong market-beating first-quarter results last week (25 April) which sent

Gatemore has over 4 million shares in ElementisShares up nearly 2% to 139p in morning tradingShareholders keen to unlock valueShareholders in Elementis (ELM) once again expressed dissatisfaction with the specialty chemicals company by writing an open letter to the board calling for change which is ?long overdue.?Liad Meidar, managing partner at Gatemore Capital Management - Gatemore Special Opport

London?s FTSE 100 hit another record high on Friday, rounding off a strong week with another gain, despite a robust US inflation reading threatening to spoil the party.The FTSE 100 index added 60.97 points, 0.8%, at 8,139.83. It is its best closing level ever, and it earlier hit a record intraday high of 8,146.75.The FTSE 250 was up 222.18 points, 1.1%, at 19,824.16, and the AIM All-Share rose 2.1

Investors bought in London at the open on Friday, with news led by Anglo American rejecting BHP?s £31.1 billion takeover offer and Darktrace accepting a $5 billion private equity takeover offer.The FTSE 100 index opened up 42.14 points, 0.5%, at 8,121.00. The FTSE 250 was up 151.94 points, 0.8%, at 19,753.92, and the AIM All-Share was up 2.41 points, 0.3%, at 755.53.The Cboe UK 100 was up 0.6% at

London?s FTSE 100 pushed higher on Thursday, leaving peers on the continent and beyond in its wake, on share price rises for heavyweights AstraZeneca, Barclays and Unilever, as well as M&A impetus for Anglo American.Trade was underwhelming elsewhere, however, as equities struggled following a red-hot US inflation reading, which was coupled with numbers showing a slowdown in growth.The FTSE 100 ind

Stock prices were up in London heading into the afternoon on Thursday, with Anglo American leading the charge on confirming it was ?reviewing? a takeover bid from its larger Australian rival BHP Group.The FTSE 100 index was up 54.22 points, 0.7%, at 8,094.60. The FTSE 250 was down 20.05 points, 0.1%, at 19,699.32, and the AIM All-Share was up 0.33 of a point at 755.02.The Cboe UK 100 was up 0.7% a

First quarter sales and profit beat expectationsStrategy update scheduled for 21 MayFull year outlook confirmedShares in AstraZeneca (AZN) surged 5% to £119.3 closing in on a new 52-week high after first quarter revenue and earnings eclipsed market expectations and the pharmaceutical company reiterated full year guidance.After a few months of consolidation, the shares are back to winning ways and

The persistently high interest rate environment means companies are under pressure to cut costs and jobs are an obvious target. While they can cut their workforce through redundancies or slash the wage bill through shorter or fewer shifts, others might already be operating with a skeleton crew and cannot pare back any further.It is against this scenario that higher wages are adding to companies? p

Chip stocks are coming under pressure from investors made nervous by hints of weakening demand during the first half of 2024. During the past week or so there have been warnings from industry bellwethers from Europe and the Far East, dampening enthusiasm just as earnings season gets going in earnest.On 22 April Taiwan Semiconductor Manufacturing Company (TSM:NYSE), or simply TSMC, the world?s bigg

Dr. Martens (DOCS) 72.1pLoss to date: 21.6%In mid-December 2023 we said the knock-down share price of iconic footwear brand Dr. Martens (DOCS) was too tempting to resist despite the company delivering four profit warnings.Our rationale was simple ? either the self-inflicted operational issues would be fixed by the current management or the business would be taken over by an opportunistic predator

Shares in Ocado (OCDO) have fallen by 20% over the past month as the online grocer continues with its fractious relationship with joint venture partner Marks & Spencer (MKS).Despite reporting average orders per week of 414,000, an 8.4% increase compared with the first quarter of 2023, and a 10.6% rise in revenue for Ocado Retail for the 13 weeks to 3 March, trouble is brewing for the online grocer

It?s been a busy month in small-cap land with good news, bad news and downright weird news for investors to digest.First the good news, as the persistent undervaluation of UK companies ? and small caps in particular ? draws increasing numbers of corporate buyers.Financial services software provider Gresham Technologies (GHT) agreed a 163p per share cash offer from funds managed or advised by STG P

Interest rates are expected to stay higher for longer to combat the sticky inflation which remains a threat to investors? hard-earned wealth and purchasing power. During periods of high inflation, it is crucial to invest in companies that possess pricing power, because these firms can pass on increased costs to customers, enabling them to maintain profit margins and generate the robust cash flows

This feature explores spin-offs or de-mergers, looking at the rationale for them and how they have performed, and asks if they can be a promising hunting ground for investors.One of the UK?s largest recent spin-offs was GSK?s (GSK) demerger of its consumer healthcare division in 2022.GSK reportedly rebuffed a £50 billion offer from personal goods giant Unilever (ULVR) to buy the division, named H

The week started with positive UK economic news as the April Rightmove (RMV) house price survey showed asking prices rising at 1.7% on last year, their biggest jump in 12 months, driven by more top-end properties coming to market.The average price of homes put up for sale reached £372,324, less than £600 short of the record level registered last May, as a revival of activity in the market prompt

Xtrackers IE Physical Gold ETC Securities (XGDU) $35.61Assets: £2.43 billionIt may have beaten a hasty retreat from recent record highs as concerns about an escalating conflict in the Middle East have eased but gold prices are still forecast in many quarters to make further gains from here.For investors concerned about geopolitical and economic risk, as inflation shows signs of being more entrenc

Stocks in London ended in the red on Wednesday, despite the FTSE 100 hitting another record high earlier in the day, while Tesla was the star in New York, where wider markets mixed.The FTSE 100 index gave back 4.43 points, 0.1%, at 8,040.38. The blue-chip index traded as high as 8,092.19 earlier Wednesday, its best-ever level. Selling pressure in the afternoon prevented it from achieving another c

Stock prices in London were up heading into the afternoon on Wednesday, with Reckitt jumping on a strong start to 2024, while Lloyds rose despite a fall in profit.The FTSE 100 index was up 38.40 points, 0.5%, at 8,083.21. The FTSE 250 was down 3.41 points at 19,796.31, and the AIM All-Share was up 0.1 of a point at 754.97.The Cboe UK 100 was up 0.5% at 807.00, the Cboe UK 250 was down 0.2% at 17,1

The FTSE 100 hit an all-time high on Tuesday, before returning some gains after somewhat hawkish words from a UK monetary policymaker.The FTSE 100 index closed up 20.94 points, 0.2%, at 8,044.81. The FTSE 250 shot up 200.33 points, 1.0%, at 19,799.72, and the AIM All-Share ended up 5.69 points, 0.8%, at 754.87.The Cboe UK 100 ended up 0.2% at 803.32, the Cboe UK 250 rose 0.9% to 17,156.66, and the

Stock prices in London rose on Tuesday heading into the afternoon, as UK economic data buoyed investors with ?fresh optimism? and helped the FTSE 100 hit another intraday high.Amongst individual stocks, AB Foods was the star of the morning, thanks to a jump in its interim profit. JD Sports also rose, after agreed to buy US sports fashion retailer Hibbett for just over $1 billion.The FTSE 100 index